Metofico

Executive Summary

Metofico is a London-based software company leveraging AI and advanced data analysis to accelerate life science research. Founded in 2018, the company offers a no-code platform for automated behavior recognition, multi-subject tracking, and fiber photometry data analysis, enabling researchers to streamline complex data workflows without programming expertise. As a pre-clinical stage company, Metofico operates in the AI / Machine Learning and Drug Delivery categories, targeting the preclinical research market. The platform's potential to reduce time and cost in behavioral neuroscience and pharmacological studies positions it as a valuable tool for academic and industrial labs. While the company has not disclosed funding, its focus on niche AI applications in life sciences suggests a promising growth trajectory, though commercialization risks remain given the competitive landscape.

Upcoming Catalysts (preview)

• Q4 2026Product launch or major update to no-code platform60% success
• TBDPartnership with a pharmaceutical or CRO for preclinical validation40% success
• Q1 2027Seed or Series A funding round announcement35% success